AWM Investment Company’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

AWM Investment Company’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-288,919	Closed	-$10.5M	–	111
2016 Q4	$10.5M	Hold	288,919	–	–	2.06%	13
2016 Q3	$11M	Buy	+288,919	New	+$4.27M	2.02%	14

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

AWM Investment Company's CLCD Position: Q1 2017 in Review

AWM Investment Company sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 288,919 shares — an estimated $10.5M sold.

AWM Investment Company first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $11M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

AWM Investment Company reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
AWM Investment Company sold 288,919 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $10.5M.
AWM Investment Company first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
AWM Investment Company's CoLucid Pharmaceuticals, Inc. position peaked at $11M in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on AWM Investment Company's 13F filing for Q1 2017, filed 12 May 2017.